期刊文献+

交感能受体阻断剂和去肾神经对5/6肾切除大鼠的肾脏保护作用 被引量:2

The Renoprotective Actions of Sympathetic Blocking Agent and Renal Denervation in the Rat Renal Ablation Model
下载PDF
导出
摘要 目的探讨交感能受体阻断剂与去肾神经对慢性进行性肾小球硬化(5/6肾切除大鼠慢性肾衰竭动物模型)的肾脏保护作用。方法雌性Wistar大鼠40只,体质量为(200±10)g,随机分成4组,每组10只。阴性对照组行假手术(麻醉后行肾周包膜剥除术),术后2周开始灌服饮用水;阳性对照组行5/6肾切除术,术后2周灌服饮用水;交感阻断剂组行5/6肾切除术,术后2周灌服交感能受体阻断剂(阿尔玛尔20 mg.kg-.1d-1);去肾神经组行5/6肾切除术后2周行残肾去肾神经术(2周后开始灌服饮用水)。干预时间为8周。所有大鼠术后第2、4、6、8、10周用鼠尾测压仪测量大鼠血压并将大鼠置于代谢笼,留取24 h尿液,之后以考马斯亮蓝法行尿蛋白定量检测;术后10周即实验结束时采血测定血红蛋白及生化指标;同时留取肾脏标本行肾脏病理、免疫印迹测定Ⅲ型胶原(Col-Ⅲ)、Ⅳ型胶原(Col-Ⅳ)及血管紧张素Ⅱ1型受体(AT1-R),应用实时荧光定量PCR检测Col-Ⅲ、Col-Ⅳ及AT1-R的mRNA的表达。结果与阴性对照组相比,阳性对照组大鼠的血压[(173.49±16.48)mmHg vs(118.67±13.34)mmHg)]和尿蛋白定量[(35.35±4.58)mg/24 h vs(6.19±2.70)mg/24 h)]均明显升高(P<0.05),肾脏病理改变明显加重(P<0.05),Col-Ⅲ、Col-Ⅳ和AT1-R及其mRNA的表达均明显增多(P<0.05);与阳性对照组相比,交感阻断剂组和去肾神经组大鼠的血压改善[(107.99±12.35)mmHg,(115.67±15.53)mmHg vs(173.49±16.48)mmHg)],尿蛋白定量减少[(14.23±0.69)mg/24 h,(16.49±3.77)mg/24 h vs(35.35±4.58)mg/24 h)](P<0.05),病理改变减轻,Col-Ⅲ、Col-Ⅳ、AT1-R及其mRNA的表达有不同程度的改善,其中尤以AT1-R的蛋白定量及其mRNA的表达明显减少(P<0.05);但两个干预组不论是血压、尿蛋白定量、血红蛋白水平、生化指标、病理改变还是Col-Ⅲ、Col-Ⅳ、AT1-R水平以及其mRNA表达均无统计学差异(P>0.05)。结论交感能受体阻断剂和去肾神经均能够明显减轻和延缓5/6肾切除大鼠的肾小球纤维化、硬化,起到良好的肾脏保护作用。 Objective To disscuss the renoprotective actions of the sympathetic blocking agent and renal denervation in the rat renal ablation model.Methods 40 wistar rats were randomly devided into 4 groups.The first group served as negative control by sham operating.The second one as positive control by 5/6 subtotal nephrectomy(SNX).The third one was underwent SNX,The fourth group underwent SNX and resection of dorsal roots,i.e.rhizotomy.The negative control,the positive control group and the fourth group were administrated tap water,the third group was given sympathetic blocking agent for 8 weeks.Results At the end of the study,the blood pressure of the rats was 118.67±13.34 mmHg in the negative control group,173.49±16.48 mmHg in the positive control group,115.67±15.53 mmHg in the third group and 107.99±12.35 mmHg in the fourth group,respectively.Albuminuria was 6.19±2.70,35.35±4.58,16.49±3.77,14.23±0.69 mg/24 h,respectively.The glomerulosclerosis of the third and fourth group were better than that of the others.The lowest indices for collagen Ⅲ,collagen Ⅳ and AT1-R were found in the third and fourth group(P〈0.05).Conclusion The sympathetic blocking agent and renal denervation can protect the remanent kidney injury.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2011年第5期400-404,共5页 Journal of China Medical University
基金 辽宁省教育厅高校科研计划(2008845)
关键词 慢性肾脏病 交感能受体阻断剂 5/6肾切除模型 去肾神经 chronic kidney disease sympathetic blocking agent 5/6 subtotal nephrectomy renal denervation
  • 相关文献

参考文献11

  • 1Koomans HA, Blankestijn PJ, Joles JA. Sympathetic hyperactivity in chronic renal failure:a wake-up call [J]. J Am Soc Nephrol,2004, 15(3):524-537.
  • 2Neumann J,Ligtenberg G,Klein II,et al. Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treat- ment [ J ]. Kidney Int, 2004,65 (5) : 1568-1576.
  • 3Campese VM, Kogosov E. Renal afferent denervation prevents hyper- tension in rats with chronic renal failure [ J ]. Hypertension, 1995,25 (4pt2) : 878-882.
  • 4Ye S,Ozgur B, Campese VM.Renal afferent impulses,the posterior hypothalamus, and hypertension in rats with chronic renal failure [ J ]. Kidney Int, 1997,51 (3) : 722-727.
  • 5Klein IH, Ligtenberg G, Neumann J, et al. Sympathetic nerve activity is inappropriately increased in chronic renal disease [ J ]. J Am Soc Nephrol, 2003,14(12) : 3239-3244.
  • 6Cerasola G,Vecchi M, Mule G,et al. Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hy- pertensives [J].Am J Nephrol, 1998,18(5) :391-398.
  • 7张承英,陈香美.交感神经兴奋在慢性肾脏病进展中的作用[J].医学综述,2007,13(10):751-753. 被引量:3
  • 8Ciriello J, de Oliveira CV. Renal afferents and hypertension [ J ].Curr Hypertens Rep, 2002,4 ( 2 ) : 136-142.
  • 9Lohmeier TE. The sympathetic nervous system and long-term blood pressure regulation [J]. Am J Hypertens,2001,14 (6pt2): 147S- 154S.
  • 10Szenasi G, Bencsath P, Szalay L,et al. Fasting induces denervation natriuresis in the conscious rat [J]. Am J Physiol,1985,249 (5pt2) : F753-F758.

二级参考文献20

  • 1Vallbo AB,Hagbarth KE,Torebjork HE,et al.Somatosensory,propriocepfive,and sympathetic activity in human peripheral nerves[J].Physiol Rev,1979,59(4):919-957.
  • 2Converse RL Jr,Jacobsen TN,Toto RD,et al.Sympathetic overactivity in patients with chronic renal failure[J].N Engl J Med,1992,327(27):1912-1918.
  • 3Levitan D,Massry SG,Romoff M,et al.Plasma catecholamines and antonomic nervous system function in patients with early renal insufficiency and hypertension:Effect of clonidine[J].Nephron,1984,36(1):24-29.
  • 4Hansberg M,Kosch M,Harmelink P,et al.Sympathetic nerve activity in end-stage renal disease[J].Circulation,2002,106(15):1974-1979.
  • 5Gampese VM,Kogesov E.Renal afferent denervation prevents hypertension in rats with chronic renal failure[J].Hypertension,1995,25(4):878-882.
  • 6Ecder T,Schrier RW.Hypertension in autosomal-dominant polycystickidney disease:Early occurrence and unique aspects[J].J Am SocNephrol,2001,12(1):194-200.
  • 7Mallamaci F,Tripepi G,Maas R,et al.Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels amongpatients with end-stage renal disease[J].J Am Soc Nephrol,2004,15(2):435-441.
  • 8Hansen J,Jacobsen TN,Victor RG.Is nitric oxide invlved in the tonic inhibition of central sympathetic outflow in humans?[J].Hypertension,1994,24(4):439-444.
  • 9Scrogin KE,Hatton DC,Chi Y,et al.Chronic nitric oxide inhibition with L-NAME:Effects on autonomic control of the cardiovascular system[J].Am J Physiol,1998,274(2):R367-R374.
  • 10Amann K,Rump LC,Simonaviciene A,et al.Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats[J].J Am Soc Nephrol,2000,11(8):1469-1478.

共引文献2

同被引文献26

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部